Stock Groups

French company Carmat announces first implant of its artificial heart in a woman By Reuters

by Mike Robinson

[ad_1]

© Reuters.

PARIS (Reuters.com – French artificial heartmaker Carmat has announced that the company had successfully implanted its Aeson artificial hearts in a woman on Tuesday.

The procedure took place at UofL Health and Jewish Hospital, performed by University of Louisville doctors.

Stephane Piat from Carmat, the CEO said “This was a significant event because we were able to complete the enrollment for the first cohort patients of the EFS [early feasibility study] but also because this device helped a woman with heart failure.”

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. Instead, they are determined by marketmakers. As such, the prices might not reflect market conditions and could be incorrect. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]